These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8357013)

  • 21. Beta-mannosidosis mice: a model for the human lysosomal storage disease.
    Zhu M; Lovell KL; Patterson JS; Saunders TL; Hughes ED; Friderici KH
    Hum Mol Genet; 2006 Feb; 15(3):493-500. PubMed ID: 16377659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphopathological features in tissues of alpha-mannosidosis guinea pigs at different gestational ages.
    Auclair D; Hopwood JJ
    Neuropathol Appl Neurobiol; 2007 Oct; 33(5):572-85. PubMed ID: 17854439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late-onset retinal dystrophy in alpha-mannosidosis.
    Springer C; Gutschalk A; Meinck HM; Rohrschneider K
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1277-9. PubMed ID: 16075219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysosomal alpha-mannosidase and alpha-mannosidosis.
    Paciotti S; Codini M; Tasegian A; Ceccarini MR; Cataldi S; Arcuri C; Fioretti B; Albi E; Beccari T
    Front Biosci (Landmark Ed); 2017 Jan; 22(1):157-167. PubMed ID: 27814608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human beta-mannosidase deficiency associated with peripheral neuropathy.
    Levade T; Graber D; Flurin V; Delisle MB; Pieraggi MT; Testut MF; Carrière JP; Salvayre R
    Ann Neurol; 1994 Jan; 35(1):116-9. PubMed ID: 8285582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental analysis of CNS pathology in the lysosomal storage disease alpha-mannosidosis.
    Crawley AC; Walkley SU
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):687-97. PubMed ID: 17882013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early onset alpha-mannosidosis with slow progression in three Hispanic males.
    Lyons MJ; Wood T; Espinoza L; Stensland HM; Holden KR
    Dev Med Child Neurol; 2007 Nov; 49(11):854-7. PubMed ID: 17979865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-mannosidosis: a new cause of spinocerebellar ataxia.
    Labauge P; Renard D; Castelnovo G; Sabourdy F; de Champfleur N; Levade T
    Clin Neurol Neurosurg; 2009 Jan; 111(1):109-10. PubMed ID: 18980795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term safety and efficacy of velmanase alfa treatment in children under 6 years of age with alpha-mannosidosis: A phase 2, open label, multicenter study.
    Guffon N; Konstantopoulou V; Hennermann JB; Muschol N; Bruno I; Tummolo A; Ceravolo F; Zardi G; Ballabeni A; Lund A
    J Inherit Metab Dis; 2023 Jul; 46(4):705-719. PubMed ID: 36849760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel storage products in human beta-mannosidosis.
    Hokke CH; Duran M; Dorland L; van Pelt J; van Sprang FJ
    J Inherit Metab Dis; 1990; 13(3):273-6. PubMed ID: 2122084
    [No Abstract]   [Full Text] [Related]  

  • 31. Structural analysis of the major urinary oligosaccharides in feline alpha-mannosidosis.
    Abraham D; Daniel P; Dell A; Oates J; Sidebotham R; Winchester B
    Biochem J; 1986 Feb; 233(3):899-904. PubMed ID: 3707532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mannosidosis. Clinical and enzymatic studies in a family].
    Pascual-Castroviejo I; Chabas A; de la Cruz M; Verdú A; Roche C
    Neurologia; 1986; 1(2):58-62. PubMed ID: 3079111
    [No Abstract]   [Full Text] [Related]  

  • 33. Human beta-mannosidosis: a 3-year-old boy with speech impairment and emotional instability.
    Poenaru L; Akli S; Rocchiccioli F; Eydoux P; Zamet P
    Clin Genet; 1992 Jun; 41(6):331-4. PubMed ID: 1623631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme replacement therapy for alpha-mannosidosis: 12 months follow-up of a single centre, randomised, multiple dose study.
    Borgwardt L; Dali CI; Fogh J; Månsson JE; Olsen KJ; Beck HC; Nielsen KG; Nielsen LH; Olsen SO; Riise Stensland HM; Nilssen O; Wibrand F; Thuesen AM; Pearl T; Haugsted U; Saftig P; Blanz J; Jones SA; Tylki-Szymanska A; Guffon-Fouiloux N; Beck M; Lund AM
    J Inherit Metab Dis; 2013 Nov; 36(6):1015-24. PubMed ID: 23494656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human mannosidosis: in vitro and in vivo studies of cofactor supplementation.
    Grabowski GA; Walling L; Desnick RJ
    Birth Defects Orig Artic Ser; 1980; 16(1):319-34. PubMed ID: 7004518
    [No Abstract]   [Full Text] [Related]  

  • 36. Alpha-mannosidosis - a review of genetic, clinical findings and options of treatment.
    Borgwardt L; Lund AM; Dali CI
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():185-91. PubMed ID: 25345101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow transplantation in the treatment of alpha-mannosidosis.
    Will A; Cooper A; Hatton C; Sardharwalla IB; Evans DI; Stevens RF
    Arch Dis Child; 1987 Oct; 62(10):1044-9. PubMed ID: 3314721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-mannosidosis: a report of 2 siblings and review of the literature.
    Govender R; Mubaiwa L
    J Child Neurol; 2014 Jan; 29(1):131-4. PubMed ID: 23307885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-mannosidosis: the first Turkish case.
    Camur S; Coşkun T; Kiper N
    Acta Paediatr Jpn; 1995 Apr; 37(2):230-2. PubMed ID: 7793263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical course of mannosidosis.
    Autio S; Louhimo T; Helenius M
    Ann Clin Res; 1982 Apr; 14(2):93-7. PubMed ID: 7149616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.